ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ACH on NYSE
Shares outstanding
77,424,733
Price per share
$2.10
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
68,967,753
Total reported value
$193,022,770
% of total 13F portfolios
0%
Share change
-3,633,429
Value change
-$21,144,446
Number of holders
161
Price from insider filings
$2.10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Coliseum Capital Management, LLC 17% +12% $62,883,874 +$7,381,690 13,100,807 +13% Coliseum Capital Management, LLC 12 Nov 2025
VANGUARD GROUP INC 7.7% $28,621,666 5,962,847 The Vanguard Group 30 Sep 2025
BlackRock, Inc. 7.1% -51% $29,888,199 -$32,238,791 5,454,051 -52% BlackRock, Inc. 30 Sep 2025
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 5.2% $8,722,670 4,057,056 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 31 Dec 2025
DIMENSIONAL FUND ADVISORS LP 4.5% $16,836,283 3,507,559 Dimensional Fund Advisors LP 30 Sep 2025
FMR LLC 3.5% -50% $18,895,342 -$21,453,010 2,718,754 -53% FMR LLC 31 Mar 2025

As of 31 Dec 2025, 161 institutional investors reported holding 68,967,753 shares of ACCENDRA HEALTH INC/VA/ - Common Stock (ACH). This represents 89% of the company’s total 77,424,733 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) together control 78% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Coliseum Capital Management, LLC 17% 13,100,807 0% 3% $36,682,260
VANGUARD GROUP INC 8.2% 6,318,285 +6% 0% $17,691,199
BlackRock, Inc. 7% 5,412,399 -3.6% 0% $15,154,718
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 5.2% 4,057,056 +26% 0% $11,359,757
D. E. Shaw & Co., Inc. 4.6% 3,558,605 +53% 0.01% $9,964,094
Invenomic Capital Management LP 4.5% 3,502,345 +27% 0.47% $9,806,566
DIMENSIONAL FUND ADVISORS LP 3.9% 3,010,865 -14% 0% $8,430,423
MILLENNIUM MANAGEMENT LLC 3.5% 2,696,881 -17% 0.01% $7,551,267
GEODE CAPITAL MANAGEMENT, LLC 2.3% 1,769,563 +21% 0% $4,955,720
PARADIGM CAPITAL MANAGEMENT INC/NY 2.2% 1,686,400 -35% 0.2% $4,721,920
BANK OF AMERICA CORP /DE/ 2.1% 1,646,875 +175% 0% $4,611,250
CITADEL ADVISORS LLC 2.1% 1,622,011 -14% 0% $4,541,631
STATE STREET CORP 2.1% 1,601,919 -18% 0% $4,485,373
Dana Investment Advisors, Inc. 1.9% 1,488,521 +18% 0.12% $4,167,859
Connor, Clark & Lunn Investment Management Ltd. 1.7% 1,281,357 +38% 0.01% $3,587,800
TWO SIGMA INVESTMENTS, LP 1.5% 1,181,668 +12% 0% $3,308,670
JANE STREET GROUP, LLC 1.4% 1,070,909 -20% 0% $2,998,545
UBS Group AG 1.1% 828,494 +40% 0% $2,319,783
Point72 Asset Management, L.P. 1% 797,377 0% $2,232,656
MORGAN STANLEY 0.99% 762,757 -52% 0% $2,135,723
ACADIAN ASSET MANAGEMENT LLC 0.93% 723,348 +199% 0% $2,021,000
GOLDMAN SACHS GROUP INC 0.86% 666,125 -4.4% 0% $1,865,150
Walleye Capital LLC 0.79% 608,231 +46% 0.01% $1,703,047
NORTHERN TRUST CORP 0.75% 580,517 -19% 0% $1,625,447
TWO SIGMA ADVISERS, LP 0.7% 542,472 +20% 0% $1,518,922

Institutional Holders of ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 68,967,753 $193,022,770 -$21,144,446 $2.80 161
2025 Q3 72,665,540 $348,919,613 -$36,289,803 $4.80 199
2025 Q2 74,911,735 $681,592,001 +$6,808,279 $9.10 231
2025 Q1 74,234,901 $669,904,220 -$41,361,744 $9.03 242
2024 Q4 75,999,880 $993,408,211 -$22,298,063 $13.07 196
2024 Q3 76,641,615 $1,202,263,604 +$5,538,488 $15.69 212
2024 Q2 77,392,783 $1,044,984,551 -$24,988,928 $13.50 219
2024 Q1 77,756,673 $2,154,498,690 +$31,589,711 $27.71 222
2023 Q4 77,989,310 $1,502,830,727 -$61,472,120 $19.27 225
2023 Q3 81,203,106 $1,312,296,789 +$96,186,745 $16.16 207
2023 Q2 75,096,359 $1,429,920,834 +$18,180,780 $19.04 224
2023 Q1 74,092,292 $1,077,976,874 -$30,742,475 $14.55 212
2022 Q4 75,706,168 $1,478,583,202 -$46,627,129 $19.53 214
2022 Q3 77,024,935 $1,855,979,184 -$50,565,219 $24.10 211
2022 Q2 78,514,995 $2,469,843,426 +$44,857,192 $31.45 240
2022 Q1 77,065,981 $3,392,912,828 +$215,548,902 $44.02 256
2021 Q4 72,003,396 $3,132,242,501 -$84,625,972 $43.50 262
2021 Q3 71,397,192 $2,234,559,466 +$52,528,014 $31.29 236
2021 Q2 68,913,037 $2,916,387,652 +$142,167,170 $42.33 256
2021 Q1 65,692,101 $2,469,466,454 +$51,163,110 $37.59 250
2020 Q4 64,815,224 $1,753,331,583 +$280,313,743 $27.05 226
2020 Q3 54,517,376 $1,364,451,183 -$17,454,505 $25.11 200
2020 Q2 56,156,110 $427,824,951 +$6,008,485 $7.62 180
2020 Q1 55,013,251 $503,242,182 -$1,599,130 $9.15 173
2019 Q4 56,885,284 $294,089,011 +$4,917,938 $5.17 169
2019 Q3 55,260,309 $321,042,234 +$8,867,057 $5.81 163
2019 Q2 54,063,804 $172,829,241 -$7,344,497 $3.20 155
2019 Q1 57,230,831 $234,625,720 -$17,910,234 $4.10 172
2018 Q4 60,021,027 $380,081,264 +$4,467,553 $6.33 197
2018 Q3 56,160,419 $927,682,202 -$4,439,169 $16.52 210
2018 Q2 56,508,484 $944,318,147 -$11,199,192 $16.71 225
2018 Q1 57,332,901 $892,355,956 -$52,551,828 $15.55 236
2017 Q4 59,755,240 $1,128,340,874 -$67,191,009 $18.88 226
2017 Q3 60,502,671 $1,767,079,541 -$14,407,441 $29.20 255
2017 Q2 60,628,276 $1,951,551,856 -$17,273,048 $32.19 272
2017 Q1 61,118,517 $2,114,657,731 +$343,821,577 $34.60 281
2016 Q4 58,484,823 $2,064,070,513 -$3,704,376 $35.29 281
2016 Q3 58,672,183 $2,034,953,793 -$109,545,808 $34.73 282
2016 Q2 61,564,008 $2,301,097,307 -$64,312,166 $37.38 279
2016 Q1 62,764,504 $2,536,801,510 -$10,762,201 $40.42 284
2015 Q4 62,769,768 $2,258,696,247 -$62,064,321 $35.98 265
2015 Q3 65,411,399 $2,089,318,781 +$86,326,122 $31.94 248
2015 Q2 62,777,529 $2,134,540,587 +$55,189,718 $34.00 236
2015 Q1 61,167,781 $2,070,230,164 +$79,726,022 $33.84 230
2014 Q4 58,749,276 $2,062,826,319 -$61,806,651 $35.11 224
2014 Q3 60,565,910 $1,982,975,741 -$39,037,233 $32.74 218
2014 Q2 61,581,555 $2,092,557,272 -$10,370,631 $33.98 237
2014 Q1 61,795,940 $2,164,654,604 -$23,709,372 $35.03 240